Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,424 across all filing types
Latest filing 2025-06-25 Regulatory Filings
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Closure of Trading window
Regulatory Filings Classification · 95% confidence The document is a notice titled 'Notice for Closure of Trading Window' issued by Sequent Scientific Limited. It informs about the closure of the trading window for insiders ahead of the announcement of unaudited financial results for the quarter ending June 30, 2025. The document does not contain any financial data or results itself, nor does it present a report. It is a regulatory announcement related to insider trading compliance and timing of financial results disclosure. The document length is short (2160 characters), and it serves as an official notification to stock exchanges and the public. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-06-25 English
Allotment of ESOP
Share Issue/Capital Change Classification · 100% confidence The document is an official communication from Sequent Scientific Limited to stock exchanges regarding the allotment of equity shares under the company's Employee Stock Option Plan (ESOP) 2020. It details the number of shares allotted, exercise price, and the resulting increase in issued and paid-up share capital. The document includes disclosures pursuant to SEBI regulations related to share-based employee benefits. There is no financial performance data, earnings information, or management discussion. The content focuses on the issuance and allotment of shares, which is a capital change event. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is about 4731 characters, which is sufficient for a detailed announcement rather than a brief notice or a report publication announcement.
2025-06-18 English
General Updates
Share Issue/Capital Change Classification · 100% confidence The document is an official communication from Sequent Scientific Limited to stock exchanges regarding the allotment of equity shares under the company's Employee Stock Option Plan (ESOP) 2020. It details the number of shares allotted, exercise price, and resulting changes in the company's share capital. The document includes regulatory disclosures pursuant to SEBI regulations related to share-based employee benefits. There are no financial statements or comprehensive financial performance data present. The content focuses on the issuance and allotment of shares, which is a capital change event. Therefore, the document fits the category of Share Issue/Capital Change (SHA). The document length is 4731 characters, which is sufficient to contain substantive information about the share allotment rather than just an announcement of a report publication or a brief notice.
2025-06-18 English
Reg. 24 (A)-Annual Secretarial Compliance
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report prepared by external Practicing Company Secretaries and filed with the stock exchanges under SEBI LODR Regulation 24A. It is neither a financial report (10-K/IR), earnings release, nor AGM/EGM voting results—it is a statutory compliance certificate and detailed compliance reporting. This falls under general regulatory filings and compliance documents, matching the Regulatory Filings (RNS) category.
2025-05-29 English
Earnings call Transcript
Call Transcript Classification · 100% confidence The document is an earnings call transcript for SeQuent Scientific Limited for the quarter and year ended March 31, 2025. It includes detailed financial performance data, management commentary, and Q&A format typical of earnings call transcripts. The text explicitly mentions it is the transcript of the earnings call and contains detailed discussion of quarterly and annual financial results, business highlights, and outlook. It is not merely an announcement or summary but a full transcript of the call. Therefore, the appropriate classification is Call Transcript (CT).
2025-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is an earnings call transcript for SeQuent Scientific Limited for the quarter and year ended March 31, 2025. It includes detailed discussions of quarterly and annual financial results, business performance, growth metrics, and strategic updates. The text explicitly mentions it is a transcript of the earnings conference call, with management speaking and answering questions. It contains substantive financial data and analysis, including revenue, EBITDA, margins, and growth percentages. The document is about 15,000 characters long, indicating it is a full transcript rather than a brief announcement or summary. Therefore, the document fits the definition of a Call Transcript (CT).
2025-05-29 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.